RecruitingNCT05854303
Effect of Opioid Cessation on Opioid-Induced Esophageal Dysfunction
Prospective Evaluation of the Effect of Opioid Cessation on Opioid-Induced Esophageal Dysfunction (OIED)
Sponsor
Mayo Clinic
Enrollment
26 participants
Start Date
Sep 18, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to evaluate the effect of opioid cessation on opioid-induced esophageal dysfunction (OIED).
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- \- Patients enrolled in the Pain Rehabilitation Center for opioid cessation, with or without esophageal symptoms.
Exclusion Criteria9
- Inability to provide informed consent.
- Patients with previous gastroesophageal surgery or pneumatic dilation.
- Esophageal botulinum toxin injection within the prior 12 months.
- Esophageal stricture
- Achalasia types I and II
- Allergy to Lidocaine or other local anesthetics
- Subjects on anticoagulation
- Bilateral nasal obstruction
- Pregnancy or breast feeding
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BEHAVIORALOpioid cessation
opioid cessation will occur during pain rehabilitative program over approximately 3 weeks
OTHERNo opioid cessation
Subjects will not stop taking opioids
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05854303